{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:20:36Z","timestamp":1787905236904,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterise the clinical and genetic profile of adult familial Mediterranean fever (FMF) patients at a German tertiary referral centre and examine genotype\u2013phenotype associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective single-centre registry study (October 2019\u2013March 2021), 95 adult FMF patients at University Hospital T\u00fcbingen were evaluated using structured questionnaires and medical record review. All patients had a pre-existing clinical diagnosis of FMF based on the Tel Hashomer and\/or Eurofever\/PRINTO criteria. Demographic data, clinical manifestations, treatment, and MEFV mutations were analysed. Patients were stratified by mutation status (homozygous M694V, heterozygous\/compound-heterozygous M694V, other mutations). Statistical analyses included the Fisher\u2013Freeman\u2013Halton exact test and ANOVA. Variants were classified according to the INSAID consensus classification; R202Q was treated as a benign polymorphism. All subgroup comparisons were exploratory and were not corrected for multiple testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median age was 36 years, with median symptom onset at 10 years. Most patients were of Turkish origin (74.7%), and 59.6% reported a family history of FMF. Common manifestations included abdominal pain (90.5%), arthralgia\/arthritis (75.8%), fever (66.3%), and chest pain (52.6%). Colchicine was used in 96.8% of patients, while 38.3% received biologic therapy, a figure influenced by concurrent participation in a tocilizumab trial at our centre. MEFV analysis had been performed in 91 of the 95 patients (95.8%); among these, at least one MEFV variant was detected in 87 (95.6%), with M694V being the most frequent variant (61.5%). Homozygous M694V patients showed earlier disease onset (nominal\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02) and higher rates of arthralgia\/arthritis (nominal\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.035). Amyloidosis occurred in one patient with homozygous M694V.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This cohort demonstrates typical FMF features with a predominance of the M694V mutation. Homozygosity for M694V is associated with earlier disease onset and increased musculoskeletal involvement. Subgroup findings are exploratory and require confirmation in independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-026-00684-2","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:14:20Z","timestamp":1787897660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and genetic characteristics of adult patients with familial Mediterranean fever at a German tertiary referral centre"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5117-0862","authenticated-orcid":false,"given":"Dorothea","family":"Reck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-6861","authenticated-orcid":false,"given":"J\u00f6rg Christoph","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-1207","authenticated-orcid":false,"given":"Sebastian Jonas","family":"Saur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"684_CR1","doi-asserted-by":"crossref","unstructured":"Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R et al. An update on familial mediterranean fever. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119584"},{"issue":"8","key":"684_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","volume":"36","author":"M Alghamdi","year":"2017","unstructured":"Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017;36(8):1707\u201313.","journal-title":"Clin Rheumatol"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"912137","DOI":"10.1155\/2015\/912137","volume":"2015","author":"F Salehzadeh","year":"2015","unstructured":"Salehzadeh F. Familial Mediterranean Fever in Iran: A Report from FMF Registration Center. Int J Rheumatol. 2015;2015:912137.","journal-title":"Int J Rheumatol"},{"issue":"1","key":"684_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","volume":"17","author":"FMF French","year":"1997","unstructured":"French FMF, Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17(1):25\u201331.","journal-title":"Nat Genet"},{"issue":"6","key":"684_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","volume":"84","author":"S Ozen","year":"2025","unstructured":"Ozen S, Sa\u011f E, Oton T, G\u00fcl A, Sieiro Santos C, Bayraktar D, et al. EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Ann Rheum Dis. 2025;84(6):899\u2013909.","journal-title":"Ann Rheum Dis"},{"key":"684_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jcm11185360","volume":"11","author":"JC Henes","year":"2022","unstructured":"Henes JC, Saur S, Kofler DM, Kedor C, Meisner C, Schuett M, et al. Tocilizumab for the Treatment of Familial Mediterranean Fever\u2014A Randomized, Double-Blind, Placebo-Controlled Phase II Study. J Clin Med. 2022;11:18.","journal-title":"J Clin Med"},{"key":"684_CR7","unstructured":"Infevers. an online database for autoinflammatory mutations. Available at https:\/\/infevers.umai-montpellier.fr\/ (accessed 8 August 2026)."},{"issue":"7","key":"684_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","volume":"9","author":"I Touitou","year":"2001","unstructured":"Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet. 2001;9(7):473\u201383.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"684_CR9","first-page":"1703","volume":"27","author":"Y Shinar","year":"2000","unstructured":"Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE, et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol. 2000;27(7):1703\u20137.","journal-title":"J Rheumatol"},{"key":"684_CR10","doi-asserted-by":"publisher","unstructured":"Ugurlu S, Kilinc OC, Karacan I, Parlar K. Familial Mediterranean fever: a comprehensive review of pathogenesis, genetics, and epigenetic regulation. Balkan Med J. 2026;43(1):3\u201314. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2025.2025-11-133","DOI":"10.4274\/balkanmedj.galenos.2025.2025-11-133"},{"issue":"12","key":"684_CR11","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s00296-024-05706-1","volume":"44","author":"R Bourguiba","year":"2024","unstructured":"Bourguiba R, Deshayes S, Amaryan G, Kone-Paut I, Belot A, Sarkisyan T, et al. Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study. Rheumatol Int. 2024;44(12):3107\u201311.","journal-title":"Rheumatol Int"},{"issue":"10","key":"684_CR12","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40(10):1879\u201385.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"684_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78(8):1025\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"684_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jmedgenet-2017-105216","volume":"55","author":"ME Van Gijn","year":"2018","unstructured":"Van Gijn ME, Ceccherini I, Shinar Y, Carbo EC, Slofstra M, Arostegui JI, et al. New workflow for classification of genetic variants\u2019 pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). J Med Genet. 2018;55(8):530\u20137.","journal-title":"J Med Genet"},{"issue":"5","key":"684_CR15","first-page":"177","volume":"77","author":"IMG Hageman","year":"2019","unstructured":"Hageman IMG, Visser H, Veenstra J, Baas F, Siegert CEH. Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam. Neth J Med. 2019;77(5):177\u201382.","journal-title":"Neth J Med"},{"issue":"2","key":"684_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3906\/sag-1809-100","volume":"49","author":"\u015e Ya\u015far Bilge","year":"2019","unstructured":"Ya\u015far Bilge \u015e, Sar\u0131 \u0130, Solmaz D, \u015eenel S, Emmungil H, K\u0131l\u0131\u00e7 L, et al. The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia. Turk J Med Sci. 2019;49(2):472\u20137.","journal-title":"Turk J Med Sci"},{"issue":"12","key":"684_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejmg.2017.09.007","volume":"60","author":"N Ebadi","year":"2017","unstructured":"Ebadi N, Shakoori A, Razipour M, Salmaninejad A, Zarifian Yeganeh R, Mehrabi S, et al. The spectrum of Familial Mediterranean Fever gene (MEFV) mutations and genotypes in Iran, and report of a novel missense variant (R204H). Eur J Med Genet. 2017;60(12):701\u20135.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"684_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5152\/eurjrheum.2020.20107","volume":"7","author":"DY Kehribar","year":"2020","unstructured":"Kehribar DY, \u00d6zgen M. The importance of Mediterranean fever gene in familial Mediterranean fever. Eur J Rheumatol. 2020;7(4):173\u20136.","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"684_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00296-019-04443-0","volume":"40","author":"H Bodur","year":"2020","unstructured":"Bodur H, Yurdakul FG, \u00c7ay HF, U\u00e7ar \u00dc, Keskin Y, Sarg\u0131n B, et al. Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort. Rheumatol Int. 2020;40(1):29\u201340.","journal-title":"Rheumatol Int"},{"issue":"10","key":"684_CR20","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/art.24458","volume":"61","author":"E Ben-Chetrit","year":"2009","unstructured":"Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009;61(10):1447\u201353.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"684_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s10067-021-06006-w","volume":"41","author":"A El Beshlawy","year":"2022","unstructured":"El Beshlawy A, Zekri AER, Ramadan MS, Selim YMM, Abdel-Salam A, Hegazy MT, et al. Genotype-phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients. Clin Rheumatol. 2022;41(5):1511\u201321.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"684_CR22","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1007\/s00431-024-05716-y","volume":"183","author":"E Aslan","year":"2024","unstructured":"Aslan E, Akay N, Gul U, Konte EK, Gunalp A, Haslak F, et al. The Impact of Different MEFV Genotypes on Clinical Phenotype of Patients with Familial Mediterranean Fever: Special Emphasis on Joint Involvement. Eur J Pediatr. 2024;183(10):4403\u201310.","journal-title":"Eur J Pediatr"},{"key":"684_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2017.05.013","volume":"626","author":"N Cekin","year":"2017","unstructured":"Cekin N, Akyurek ME, Pinarbasi E, Ozen F. MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever. Gene. 2017;626:9\u201313.","journal-title":"Gene"},{"issue":"1","key":"684_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00296-020-04592-7","volume":"41","author":"NA Ayaz","year":"2021","unstructured":"Ayaz NA, Tanatar A, Karada\u011f \u015e G, \u00c7akan M, Keskindemirci G, S\u00f6nmez HE. Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever. Rheumatol Int. 2021;41(1):113\u201320.","journal-title":"Rheumatol Int"},{"key":"684_CR25","doi-asserted-by":"publisher","unstructured":"Tuncer Kuru F, Gokcen N, Yazici A, Cefle A. Disease severity and genotype-phenotype correlation in adult patients with familial Mediterranean fever. Mod Rheumatol. 2024;34(1):214\u20139. https:\/\/doi.org\/10.1093\/mr\/road007","DOI":"10.1093\/mr\/road007"},{"issue":"1","key":"684_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/302459","volume":"65","author":"C Cazeneuve","year":"1999","unstructured":"Cazeneuve C, Sarkisian T, P\u00eacheux C, Dervichian M, N\u00e9delec B, Reinert P, et al. MEFV-Gene Analysis in Armenian Patients with Familial Mediterranean Fever: Diagnostic Value and Unfavorable Renal Prognosis of the M694V Homozygous Genotype\u2014Genetic and Therapeutic Implications. Am J Hum Genet. 1999;65(1):88\u201397.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"684_CR27","doi-asserted-by":"publisher","first-page":"105888","DOI":"10.1016\/j.jbspin.2025.105888","volume":"92","author":"E Tunce","year":"2025","unstructured":"Tunce E, Atamyildiz U\u00e7ar S, S\u00f6zeri B. Different arthritis patterns in pediatric familial Mediterranean fever: Focus on exon 10 biallelic pathogenic genotypes. Joint Bone Spine. 2025;92(5):105888. PMID 40096885.","journal-title":"Joint Bone Spine"},{"issue":"8","key":"684_CR28","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1093\/rheumatology\/keaf221","volume":"64","author":"E Tunce","year":"2025","unstructured":"Tunce E, Ucar S, Polat M, G\u00fccenmez \u00d6, Cakan M, Y\u00fccel B, et al. Predicting homozygous M694V genotype in paediatric familial Mediterranean fever: multicentre analysis and scoring system proposal. Rheumatology (Oxford). 2025;64(8):4816\u201324. PMID 40257440.","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 121","key":"684_CR29","first-page":"119","volume":"37","author":"M Erdogan","year":"2019","unstructured":"Erdogan M, Ugurlu S, Ozdogan H, Seyahi E. Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey. Clin Exp Rheumatol. 2019;37(Suppl 121):119\u201324.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"684_CR30","first-page":"1","volume":"84","author":"Turkish FMF Study Group","year":"2005","unstructured":"Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Med (Baltim). 2005;84(1):1\u201311.","journal-title":"Med (Baltim)"},{"issue":"2","key":"684_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1742-1241.2004.00294.x","volume":"59","author":"M Sayarlioglu","year":"2005","unstructured":"Sayarlioglu M, Cefle A, Inanc M, Kamali S, Dalkilic E, Gul A, et al. Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract. 2005;59(2):202\u20135.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"684_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-009-9475-9","volume":"37","author":"RA Jarjour","year":"2010","unstructured":"Jarjour RA. Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation. Mol Biol Rep. 2010;37(1):1\u20135.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"684_CR33","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/art.22507","volume":"56","author":"I Touitou","year":"2007","unstructured":"Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial mediterranean fever. Arthritis Rheum. 2007;56(5):1706\u201312.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"684_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/ard.2008.092031","volume":"68","author":"S Ozen","year":"2009","unstructured":"Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2009;68(2):246\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"684_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/rheumatology\/kev315","volume":"55","author":"S Akar","year":"2016","unstructured":"Akar S, Solmaz D, Kasifoglu T, Bilge SY, Sari I, Gumus ZZ, et al. Different disease subtypes with distinct clinical expression in familial Mediterranean fever: results of a cluster analysis. Rheumatology (Oxford). 2016;55(2):343\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"684_CR36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1034\/j.1399-0004.2000.570605.x","volume":"57","author":"M Tekin","year":"2000","unstructured":"Tekin M, Yal\u00e7inkaya F, Cakar N, Akar N, Misirlio\u011flu M, Ta\u015ftan H, et al. MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet. 2000;57(6):430\u20134.","journal-title":"Clin Genet"},{"issue":"1","key":"684_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/rheumatology\/39.1.67","volume":"39","author":"F Yal\u00e7inkaya","year":"2000","unstructured":"Yal\u00e7inkaya F, Cakar N, Misirlio\u011flu M, T\u00fcmer N, Akar N, Tekin M, et al. Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford). 2000;39(1):67\u201372.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"684_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1399-0004.2007.00789.x","volume":"71","author":"S Giaglis","year":"2007","unstructured":"Giaglis S, Mimidis K, Papadopoulos V, Thomopoulos K, Sidiropoulos P, Rafail S, et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet. 2007;71(5):458\u201367.","journal-title":"Clin Genet"},{"issue":"6","key":"684_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/s-0033-1355372","volume":"225","author":"M Jeske","year":"2013","unstructured":"Jeske M, Lainka E, Kone-Paut I, Livneh A, Hentgen V, Kivity S, et al. Genotype-phenotype and genotype-origin correlations in children with Mediterranean fever in Germany \u2013 an AID-net study. Klin Padiatr. 2013;225(6):325\u201330.","journal-title":"Klin Padiatr"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00684-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00684-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00684-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:02:52Z","timestamp":1787904172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00684-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00684-2","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol (project no. 505\/2019BO2) was approved by the Ethics Committee of the Medical Faculty of Eberhard Karls University and University Hospital T\u00fcbingen in August 2019. All procedures involving human participants were conducted in accordance with the principles of the Declaration of Helsinki and with the relevant local ethical guidelines. All participants received written and oral information about the study and provided written informed consent prior to inclusion.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"65"}}